Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global COVID-19 Rapid Antibody Test Kits Market Research Report 2026

Global COVID-19 Rapid Antibody Test Kits Market Research Report 2026

Industry: Medical Devices & Consumables

Published Date: 2026-04-17

Pages: 126 Pages

Report ld: 6468565

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

COVID-19 Rapid Antibody Test Kits Market Size(US$)

CAGR 2026-2032

-21.7%

Market Size,2032

USD 1,873

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 8,126 million

Market Forecast in 2032(Value)

US$ 1,873 million

CAGR

-21.7%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global COVID-19 Rapid Antibody Test Kits market was valued at US$ 10100 million in 2025 and is anticipated to reach US$ 1873 million by 2032, at a CAGR of -21.7% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on COVID-19 Rapid Antibody Test Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.

The North American market for COVID-19 Rapid Antibody Test Kits is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for COVID-19 Rapid Antibody Test Kits is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of COVID-19 Rapid Antibody Test Kits include RayBiotech Life, Aurora Biomed, SD Biosensor, Abingdon Health, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics, TestLine Clinical Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global COVID-19 Rapid Antibody Test Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding COVID-19 Rapid Antibody Test Kits. The COVID-19 Rapid Antibody Test Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global COVID-19 Rapid Antibody Test Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist COVID-19 Rapid Antibody Test Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

RayBiotech Life
Aurora Biomed
SD Biosensor
Abingdon Health
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

IgG Test
IgM Test
Others

Segment by Application

Hospital
Company
School
Home
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Provides a detailed analysis of the competitive landscape for COVID-19 Rapid Antibody Test Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.

Chapter 3: Examines COVID-19 Rapid Antibody Test Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.

Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.

Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.

Chapter 7: Reviews the industry value chain, including upstream and downstream segments.

Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.

Chapter 9: Summarizes the key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 COVID-19 Rapid Antibody Test Kits Market Overview

1.1 Product Definition

1.2 COVID-19 Rapid Antibody Test Kits by Type

1.2.1 Global COVID-19 Rapid Antibody Test Kits Market Value by Type: 2025 vs 2032

1.2.2 IgG Test

1.2.3 IgM Test

1.2.4 Others

1.3 COVID-19 Rapid Antibody Test Kits by Application

1.3.1 Global COVID-19 Rapid Antibody Test Kits Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Company

1.3.4 School

1.3.5 Home

1.3.6 Others

1.4 Global COVID-19 Rapid Antibody Test Kits Market Size Estimates and Forecasts

1.4.1 Global COVID-19 Rapid Antibody Test Kits Revenue 2021–2032

1.4.2 Global COVID-19 Rapid Antibody Test Kits Sales 2021–2032

1.4.3 Global COVID-19 Rapid Antibody Test Kits Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 COVID-19 Rapid Antibody Test Kits Market Competition by Manufacturers

2.1 Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Manufacturers (2021–2026)

2.2 Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Manufacturers (2021–2026)

2.3 Global COVID-19 Rapid Antibody Test Kits Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of COVID-19 Rapid Antibody Test Kits, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Product Types and Applications

2.7 Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Date of Entry into the Industry

2.8 Global COVID-19 Rapid Antibody Test Kits Market Competitive Situation and Trends

2.8.1 Global COVID-19 Rapid Antibody Test Kits Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global COVID-19 Rapid Antibody Test Kits Players Market Share by Revenue

2.8.3 Global COVID-19 Rapid Antibody Test Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global COVID-19 Rapid Antibody Test Kits Market Scenario by Region

3.1 Global COVID-19 Rapid Antibody Test Kits Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global COVID-19 Rapid Antibody Test Kits Sales by Region: 2021–2032

3.2.1 Global COVID-19 Rapid Antibody Test Kits Sales by Region: 2021–2026

3.2.2 Global COVID-19 Rapid Antibody Test Kits Sales by Region: 2027–2032

3.3 Global COVID-19 Rapid Antibody Test Kits Revenue by Region: 2021–2032

3.3.1 Global COVID-19 Rapid Antibody Test Kits Revenue by Region: 2021–2026

3.3.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Region: 2027–2032

3.4 North America COVID-19 Rapid Antibody Test Kits Market Facts & Figures by Country

3.4.1 North America COVID-19 Rapid Antibody Test Kits Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America COVID-19 Rapid Antibody Test Kits Sales by Country (2021–2032)

3.4.3 North America COVID-19 Rapid Antibody Test Kits Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe COVID-19 Rapid Antibody Test Kits Market Facts & Figures by Country

3.5.1 Europe COVID-19 Rapid Antibody Test Kits Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe COVID-19 Rapid Antibody Test Kits Sales by Country (2021–2032)

3.5.3 Europe COVID-19 Rapid Antibody Test Kits Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific COVID-19 Rapid Antibody Test Kits Market Facts & Figures by Region

3.6.1 Asia Pacific COVID-19 Rapid Antibody Test Kits Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific COVID-19 Rapid Antibody Test Kits Sales by Region (2021–2032)

3.6.3 Asia Pacific COVID-19 Rapid Antibody Test Kits Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America COVID-19 Rapid Antibody Test Kits Market Facts & Figures by Country

3.7.1 Latin America COVID-19 Rapid Antibody Test Kits Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America COVID-19 Rapid Antibody Test Kits Sales by Country (2021–2032)

3.7.3 Latin America COVID-19 Rapid Antibody Test Kits Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa COVID-19 Rapid Antibody Test Kits Market Facts & Figures by Country

3.8.1 Middle East and Africa COVID-19 Rapid Antibody Test Kits Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales by Country (2021–2032)

3.8.3 Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global COVID-19 Rapid Antibody Test Kits Sales by Type (2021–2032)

4.1.1 Global COVID-19 Rapid Antibody Test Kits Sales by Type (2021–2026)

4.1.2 Global COVID-19 Rapid Antibody Test Kits Sales by Type (2027–2032)

4.1.3 Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Type (2021–2032)

4.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Type (2021–2032)

4.2.1 Global COVID-19 Rapid Antibody Test Kits Revenue by Type (2021–2026)

4.2.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Type (2027–2032)

4.2.3 Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Type (2021–2032)

4.3 Global COVID-19 Rapid Antibody Test Kits Price by Type (2021–2032)

5 Segment by Application

5.1 Global COVID-19 Rapid Antibody Test Kits Sales by Application (2021–2032)

5.1.1 Global COVID-19 Rapid Antibody Test Kits Sales by Application (2021–2026)

5.1.2 Global COVID-19 Rapid Antibody Test Kits Sales by Application (2027–2032)

5.1.3 Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Application (2021–2032)

5.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Application (2021–2032)

5.2.1 Global COVID-19 Rapid Antibody Test Kits Revenue by Application (2021–2026)

5.2.2 Global COVID-19 Rapid Antibody Test Kits Revenue by Application (2027–2032)

5.2.3 Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Application (2021–2032)

5.3 Global COVID-19 Rapid Antibody Test Kits Price by Application (2021–2032)

6 Key Companies Profiled

6.1 RayBiotech Life

6.1.1 RayBiotech Life Company Information

6.1.2 RayBiotech Life Description and Business Overview

6.1.3 RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 RayBiotech Life COVID-19 Rapid Antibody Test Kits Product Portfolio

6.1.5 RayBiotech Life Recent Developments/Updates

6.2 Aurora Biomed

6.2.1 Aurora Biomed Company Information

6.2.2 Aurora Biomed Description and Business Overview

6.2.3 Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Aurora Biomed COVID-19 Rapid Antibody Test Kits Product Portfolio

6.2.5 Aurora Biomed Recent Developments/Updates

6.3 SD Biosensor

6.3.1 SD Biosensor Company Information

6.3.2 SD Biosensor Description and Business Overview

6.3.3 SD Biosensor COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 SD Biosensor COVID-19 Rapid Antibody Test Kits Product Portfolio

6.3.5 SD Biosensor Recent Developments/Updates

6.4 Abingdon Health

6.4.1 Abingdon Health Company Information

6.4.2 Abingdon Health Description and Business Overview

6.4.3 Abingdon Health COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Abingdon Health COVID-19 Rapid Antibody Test Kits Product Portfolio

6.4.5 Abingdon Health Recent Developments/Updates

6.5 INSTI

6.5.1 INSTI Company Information

6.5.2 INSTI Description and Business Overview

6.5.3 INSTI COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 INSTI COVID-19 Rapid Antibody Test Kits Product Portfolio

6.5.5 INSTI Recent Developments/Updates

6.6 CTK Biotech

6.6.1 CTK Biotech Company Information

6.6.2 CTK Biotech Description and Business Overview

6.6.3 CTK Biotech COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 CTK Biotech COVID-19 Rapid Antibody Test Kits Product Portfolio

6.6.5 CTK Biotech Recent Developments/Updates

6.7 SBL Testing Technologies

6.7.1 SBL Testing Technologies Company Information

6.7.2 SBL Testing Technologies Description and Business Overview

6.7.3 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Product Portfolio

6.7.5 SBL Testing Technologies Recent Developments/Updates

6.8 Biopanda

6.8.1 Biopanda Company Information

6.8.2 Biopanda Description and Business Overview

6.8.3 Biopanda COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Biopanda COVID-19 Rapid Antibody Test Kits Product Portfolio

6.8.5 Biopanda Recent Developments/Updates

6.9 Roche Diagnostics

6.9.1 Roche Diagnostics Company Information

6.9.2 Roche Diagnostics Description and Business Overview

6.9.3 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Roche Diagnostics COVID-19 Rapid Antibody Test Kits Product Portfolio

6.9.5 Roche Diagnostics Recent Developments/Updates

6.10 TestLine Clinical Diagnostics

6.10.1 TestLine Clinical Diagnostics Company Information

6.10.2 TestLine Clinical Diagnostics Description and Business Overview

6.10.3 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Product Portfolio

6.10.5 TestLine Clinical Diagnostics Recent Developments/Updates

6.11 Assay Genie

6.11.1 Assay Genie Company Information

6.11.2 Assay Genie Description and Business Overview

6.11.3 Assay Genie COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Assay Genie COVID-19 Rapid Antibody Test Kits Product Portfolio

6.11.5 Assay Genie Recent Developments/Updates

6.12 Nadal-test

6.12.1 Nadal-test Company Information

6.12.2 Nadal-test Description and Business Overview

6.12.3 Nadal-test COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Nadal-test COVID-19 Rapid Antibody Test Kits Product Portfolio

6.12.5 Nadal-test Recent Developments/Updates

6.13 Panodyne

6.13.1 Panodyne Company Information

6.13.2 Panodyne Description and Business Overview

6.13.3 Panodyne COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Panodyne COVID-19 Rapid Antibody Test Kits Product Portfolio

6.13.5 Panodyne Recent Developments/Updates

6.14 Luminex

6.14.1 Luminex Company Information

6.14.2 Luminex Description and Business Overview

6.14.3 Luminex COVID-19 Rapid Antibody Test Kits Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Luminex COVID-19 Rapid Antibody Test Kits Product Portfolio

6.14.5 Luminex Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 COVID-19 Rapid Antibody Test Kits Industry Chain Analysis

7.2 COVID-19 Rapid Antibody Test Kits Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 COVID-19 Rapid Antibody Test Kits Production Mode & Process Analysis

7.4 COVID-19 Rapid Antibody Test Kits Sales and Marketing

7.4.1 COVID-19 Rapid Antibody Test Kits Sales Channels

7.4.2 COVID-19 Rapid Antibody Test Kits Distributors

7.5 COVID-19 Rapid Antibody Test Kits Customer Analysis

8 COVID-19 Rapid Antibody Test Kits Market Dynamics

8.1 COVID-19 Rapid Antibody Test Kits Industry Trends

8.2 COVID-19 Rapid Antibody Test Kits Market Drivers

8.3 COVID-19 Rapid Antibody Test Kits Market Challenges

8.4 COVID-19 Rapid Antibody Test Kits Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global COVID-19 Rapid Antibody Test Kits Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global COVID-19 Rapid Antibody Test Kits Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global COVID-19 Rapid Antibody Test Kits Market Competitive Situation by Manufacturers in 2025

Table 4. Global COVID-19 Rapid Antibody Test Kits Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Manufacturers (2021–2026)

Table 6. Global COVID-19 Rapid Antibody Test Kits Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global COVID-19 Rapid Antibody Test Kits Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market COVID-19 Rapid Antibody Test Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of COVID-19 Rapid Antibody Test Kits, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Product Types and Applications

Table 12. Global Key Manufacturers of COVID-19 Rapid Antibody Test Kits, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global COVID-19 Rapid Antibody Test Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on COVID-19 Rapid Antibody Test Kits Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global COVID-19 Rapid Antibody Test Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global COVID-19 Rapid Antibody Test Kits Sales by Region (K Units), 2021–2026

Table 18. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Region (2021–2026)

Table 19. Global COVID-19 Rapid Antibody Test Kits Sales by Region (K Units), 2027–2032

Table 20. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Region (2027–2032)

Table 21. Global COVID-19 Rapid Antibody Test Kits Revenue by Region (US$ Million), 2021–2026

Table 22. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Region (2021–2026)

Table 23. Global COVID-19 Rapid Antibody Test Kits Revenue by Region (US$ Million), 2027–2032

Table 24. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Region (2027–2032)

Table 25. North America COVID-19 Rapid Antibody Test Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2021–2026

Table 27. North America COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2027–2032

Table 28. North America COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2021–2026

Table 29. North America COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2027–2032

Table 30. Europe COVID-19 Rapid Antibody Test Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2021–2026

Table 32. Europe COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2027–2032

Table 33. Europe COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2021–2026

Table 34. Europe COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific COVID-19 Rapid Antibody Test Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific COVID-19 Rapid Antibody Test Kits Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific COVID-19 Rapid Antibody Test Kits Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific COVID-19 Rapid Antibody Test Kits Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific COVID-19 Rapid Antibody Test Kits Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America COVID-19 Rapid Antibody Test Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2021–2026

Table 42. Latin America COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2027–2032

Table 43. Latin America COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue by Country (US$ Million), 2027–2032

Table 50. Global COVID-19 Rapid Antibody Test Kits Sales (K Units) by Type (2021–2026)

Table 51. Global COVID-19 Rapid Antibody Test Kits Sales (K Units) by Type (2027–2032)

Table 52. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Type (2021–2026)

Table 53. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Type (2027–2032)

Table 54. Global COVID-19 Rapid Antibody Test Kits Revenue (US$ Million) by Type (2021–2026)

Table 55. Global COVID-19 Rapid Antibody Test Kits Revenue (US$ Million) by Type (2027–2032)

Table 56. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Type (2021–2026)

Table 57. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Type (2027–2032)

Table 58. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Type (2021–2026)

Table 59. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Type (2027–2032)

Table 60. Global COVID-19 Rapid Antibody Test Kits Sales (K Units) by Application (2021–2026)

Table 61. Global COVID-19 Rapid Antibody Test Kits Sales (K Units) by Application (2027–2032)

Table 62. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Application (2021–2026)

Table 63. Global COVID-19 Rapid Antibody Test Kits Sales Market Share by Application (2027–2032)

Table 64. Global COVID-19 Rapid Antibody Test Kits Revenue (US$ Million) by Application (2021–2026)

Table 65. Global COVID-19 Rapid Antibody Test Kits Revenue (US$ Million) by Application (2027–2032)

Table 66. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Application (2021–2026)

Table 67. Global COVID-19 Rapid Antibody Test Kits Revenue Market Share by Application (2027–2032)

Table 68. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Application (2021–2026)

Table 69. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Application (2027–2032)

Table 70. RayBiotech Life Company Information

Table 71. RayBiotech Life Description and Business Overview

Table 72. RayBiotech Life COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. RayBiotech Life COVID-19 Rapid Antibody Test Kits Product

Table 74. RayBiotech Life Recent Developments/Updates

Table 75. Aurora Biomed Company Information

Table 76. Aurora Biomed Description and Business Overview

Table 77. Aurora Biomed COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Aurora Biomed COVID-19 Rapid Antibody Test Kits Product

Table 79. Aurora Biomed Recent Developments/Updates

Table 80. SD Biosensor Company Information

Table 81. SD Biosensor Description and Business Overview

Table 82. SD Biosensor COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. SD Biosensor COVID-19 Rapid Antibody Test Kits Product

Table 84. SD Biosensor Recent Developments/Updates

Table 85. Abingdon Health Company Information

Table 86. Abingdon Health Description and Business Overview

Table 87. Abingdon Health COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Abingdon Health COVID-19 Rapid Antibody Test Kits Product

Table 89. Abingdon Health Recent Developments/Updates

Table 90. INSTI Company Information

Table 91. INSTI Description and Business Overview

Table 92. INSTI COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. INSTI COVID-19 Rapid Antibody Test Kits Product

Table 94. INSTI Recent Developments/Updates

Table 95. CTK Biotech Company Information

Table 96. CTK Biotech Description and Business Overview

Table 97. CTK Biotech COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. CTK Biotech COVID-19 Rapid Antibody Test Kits Product

Table 99. CTK Biotech Recent Developments/Updates

Table 100. SBL Testing Technologies Company Information

Table 101. SBL Testing Technologies Description and Business Overview

Table 102. SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. SBL Testing Technologies COVID-19 Rapid Antibody Test Kits Product

Table 104. SBL Testing Technologies Recent Developments/Updates

Table 105. Biopanda Company Information

Table 106. Biopanda Description and Business Overview

Table 107. Biopanda COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Biopanda COVID-19 Rapid Antibody Test Kits Product

Table 109. Biopanda Recent Developments/Updates

Table 110. Roche Diagnostics Company Information

Table 111. Roche Diagnostics Description and Business Overview

Table 112. Roche Diagnostics COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 113. Roche Diagnostics COVID-19 Rapid Antibody Test Kits Product

Table 114. Roche Diagnostics Recent Developments/Updates

Table 115. TestLine Clinical Diagnostics Company Information

Table 116. TestLine Clinical Diagnostics Description and Business Overview

Table 117. TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 118. TestLine Clinical Diagnostics COVID-19 Rapid Antibody Test Kits Product

Table 119. TestLine Clinical Diagnostics Recent Developments/Updates

Table 120. Assay Genie Company Information

Table 121. Assay Genie Description and Business Overview

Table 122. Assay Genie COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 123. Assay Genie COVID-19 Rapid Antibody Test Kits Product

Table 124. Assay Genie Recent Developments/Updates

Table 125. Nadal-test Company Information

Table 126. Nadal-test Description and Business Overview

Table 127. Nadal-test COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 128. Nadal-test COVID-19 Rapid Antibody Test Kits Product

Table 129. Nadal-test Recent Developments/Updates

Table 130. Panodyne Company Information

Table 131. Panodyne Description and Business Overview

Table 132. Panodyne COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 133. Panodyne COVID-19 Rapid Antibody Test Kits Product

Table 134. Panodyne Recent Developments/Updates

Table 135. Luminex Company Information

Table 136. Luminex Description and Business Overview

Table 137. Luminex COVID-19 Rapid Antibody Test Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 138. Luminex COVID-19 Rapid Antibody Test Kits Product

Table 139. Luminex Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. COVID-19 Rapid Antibody Test Kits Distributors List

Table 143. COVID-19 Rapid Antibody Test Kits Customers List

Table 144. COVID-19 Rapid Antibody Test Kits Market Trends

Table 145. COVID-19 Rapid Antibody Test Kits Market Drivers

Table 146. COVID-19 Rapid Antibody Test Kits Market Challenges

Table 147. COVID-19 Rapid Antibody Test Kits Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of COVID-19 Rapid Antibody Test Kits

Figure 2. Global COVID-19 Rapid Antibody Test Kits Market Value by Type (US$ Million), 2021–2032

Figure 3. Global COVID-19 Rapid Antibody Test Kits Market Share by Type: 2025 & 2032

Figure 4. IgG Test Product Picture

Figure 5. IgM Test Product Picture

Figure 6. Others Product Picture

Figure 7. Global COVID-19 Rapid Antibody Test Kits Market Value by Application (US$ Million), 2021–2032

Figure 8. Global COVID-19 Rapid Antibody Test Kits Market Share by Application: 2025 & 2032

Figure 9. Hospital

Figure 10. Company

Figure 11. School

Figure 12. Home

Figure 13. Others

Figure 14. Global COVID-19 Rapid Antibody Test Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global COVID-19 Rapid Antibody Test Kits Market Size (US$ Million), 2021–2032

Figure 16. Global COVID-19 Rapid Antibody Test Kits Sales (K Units), 2021–2032

Figure 17. Global COVID-19 Rapid Antibody Test Kits Average Price (US$/Unit), 2021–2032

Figure 18. COVID-19 Rapid Antibody Test Kits Report Years Considered

Figure 19. COVID-19 Rapid Antibody Test Kits Sales Share by Manufacturers in 2025

Figure 20. Global COVID-19 Rapid Antibody Test Kits Revenue Share by Manufacturers in 2025

Figure 21. Top 5 and Top 10 Global COVID-19 Rapid Antibody Test Kits Players: Market Share by Revenue in COVID-19 Rapid Antibody Test Kits in 2025

Figure 22. COVID-19 Rapid Antibody Test Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 23. Global COVID-19 Rapid Antibody Test Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 24. North America COVID-19 Rapid Antibody Test Kits Sales Market Share by Country (2021–2032)

Figure 25. North America COVID-19 Rapid Antibody Test Kits Revenue Market Share by Country (2021–2032)

Figure 26. United States COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Canada COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. Europe COVID-19 Rapid Antibody Test Kits Sales Market Share by Country (2021–2032)

Figure 29. Europe COVID-19 Rapid Antibody Test Kits Revenue Market Share by Country (2021–2032)

Figure 30. Germany COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. France COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. U.K. COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Italy COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Russia COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Asia Pacific COVID-19 Rapid Antibody Test Kits Sales Market Share by Region (2021–2032)

Figure 36. Asia Pacific COVID-19 Rapid Antibody Test Kits Revenue Market Share by Region (2021–2032)

Figure 37. China COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Japan COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. South Korea COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. India COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Australia COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. China Taiwan COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Indonesia COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Thailand COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Malaysia COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America COVID-19 Rapid Antibody Test Kits Sales Market Share by Country (2021–2032)

Figure 47. Latin America COVID-19 Rapid Antibody Test Kits Revenue Market Share by Country (2021–2032)

Figure 48. Mexico COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Middle East and Africa COVID-19 Rapid Antibody Test Kits Sales Market Share by Country (2021–2032)

Figure 52. Middle East and Africa COVID-19 Rapid Antibody Test Kits Revenue Market Share by Country (2021–2032)

Figure 53. Turkey COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Saudi Arabia COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. UAE COVID-19 Rapid Antibody Test Kits Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Global Sales Market Share of COVID-19 Rapid Antibody Test Kits by Type (2021–2032)

Figure 57. Global Revenue Market Share of COVID-19 Rapid Antibody Test Kits by Type (2021–2032)

Figure 58. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Type (2021–2032)

Figure 59. Global Sales Market Share of COVID-19 Rapid Antibody Test Kits by Application (2021–2032)

Figure 60. Global Revenue Market Share of COVID-19 Rapid Antibody Test Kits by Application (2021–2032)

Figure 61. Global COVID-19 Rapid Antibody Test Kits Price (US$/Unit) by Application (2021–2032)

Figure 62. COVID-19 Rapid Antibody Test Kits Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, -21.7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global COVID-19 Rapid Antibody Test Kits market? shouQi

What is the annual compound growth rate of the global COVID-19 Rapid Antibody Test Kits market size from 2026 to 2032? shouQi

What was the global market size of COVID-19 Rapid Antibody Test Kits in 2026? shouQi

What was the global market size of COVID-19 Rapid Antibody Test Kits in 2032? shouQi

Related Reports

COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
The global COVID-19 Rapid Antibody Test Kits market is projected to grow from US$ 12550 million in 2024 to US$ 2327 million by 2031, at a CAGR of -21.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 155
USD 4900.00
(Single User License)
COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 127
USD 3950.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2025
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2024
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published Date: 2024-01-17
Pages: 89
USD 2900.00
(Single User License)

COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 10100 million in 2025 and is projected to reach US$ 1873 million, growing at a CAGR of -21.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 139
USD 3950.00 (Single User License)
Global COVID-19 Rapid Antibody Test Kits Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global COVID-19 Rapid Antibody Test Kits market size was US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
USD 4250.00 (Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Outlook, In‑Depth Analysis & Forecast to 2031
The global COVID-19 Rapid Antibody Test Kits market is projected to grow from US$ 12550 million in 2024 to US$ 2327 million by 2031, at a CAGR of -21.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 155
USD 4900.00 (Single User License)
COVID-19 Rapid Antibody Test Kits- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for COVID-19 Rapid Antibody Test Kits was estimated to be worth US$ 12550 million in 2024 and is forecast to a readjusted size of US$ 2327 million by 2031 with a CAGR of -21.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 127
USD 3950.00 (Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2025
The global market for COVID-19 Rapid Antibody Test Kits was valued at US$ 12550 million in the year 2024 and is projected to reach a revised size of US$ 2327 million by 2031, growing at a CAGR of -21.7% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)
Global COVID-19 Rapid Antibody Test Kits Market Research Report 2024
In response to the Coronavirus (COVID-19) pandemic, IgM/IgG antibody rapid test kit to equip healthcare workers for rapid COVID-19 antibody detection. This COVID-19 Rapid Test Kit is suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. Common signs of infection with SARS-CoV-2 include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure, and even death. SARS-CoV-2 can be excreted through respiratory secretions or transmitted through oral fluids, sneezing, physical contact, and through air droplets.
Published: 2024-01-17
Pages: 89
USD 2900.00 (Single User License)